SCHEMBL6003393

SCHEMBL6003393

CCc1scc2cccc(Cl)c12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.36
KDM4E B2RXH2 3/20 0.36
L3MBTL1 Q9Y468 3/20 0.36
MAPK1 P28482 1/20 0.36
CDK5 Q00535 2/20 0.34
CDK5R1 Q15078 2/20 0.34
CCNA2 P20248 1/20 0.34
CDK2 P24941 1/20 0.34
CCNA1 P78396 1/20 0.34
CYP1A2 P05177 2/20 0.33
CYP2A6 P11509 2/20 0.33
DHFR P00374 1/20 0.33
TYMS P04818 1/20 0.33
NPC1 O15118 1/20 0.33
MAPT P10636 1/20 0.33
RAB9A P51151 1/20 0.33
POLB P06746 1/20 0.33
TDP1 Q9NUW8 1/20 0.31
MEN1 O00255 1/20 0.31
TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2093803 0.81 CYP1A2 (0.33) ALDH1A1KDM4EL3MBTL1CYP1A2CYP2A6
SCHEMBL6002696 0.78 KDM4E (0.36) ALDH1A1KDM4EL3MBTL1CYP1A2CYP2A6
SCHEMBL2094483 0.75 CYP2A6 (0.37) ALDH1A1KDM4EL3MBTL1MAPK1CYP1A2
SCHEMBL2095389 0.74
SCHEMBL6002428 0.72 CYP1A2 (0.44) ALDH1A1KDM4EL3MBTL1CYP1A2CYP2A6
SCHEMBL2094479 0.71 CYP2A6 (0.41) ALDH1A1KDM4EL3MBTL1MAPK1CYP1A2
SCHEMBL24970521 0.68 GABRA1 (0.45) ALDH1A1KDM4EMAPK1CYP1A2CYP2A6
SCHEMBL2090417 0.68 CYP2A6 (0.38) ALDH1A1KDM4ECYP1A2CYP2A6MAPT
SCHEMBL6002815 0.67 ALDH1A1 (0.39) ALDH1A1KDM4EL3MBTL1MAPK1CYP1A2
SCHEMBL29620231 0.65 TSHR (0.53) ALDH1A1KDM4EL3MBTL1MAPK1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678185-A1 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-07-12 EP disclosed
WO-2005042542-A1 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-05-12 WO disclosed